BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12417041)

  • 1. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers.
    Watanabe T; Imoto I; Katahira T; Hirasawa A; Ishiwata I; Emi M; Takayama M; Sato A; Inazawa J
    Jpn J Cancer Res; 2002 Oct; 93(10):1114-22. PubMed ID: 12417041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells.
    Chung CM; Man C; Jin Y; Jin C; Guan XY; Wang Q; Wan TS; Cheung AL; Tsao SW
    Mol Carcinog; 2005 Jul; 43(3):165-74. PubMed ID: 15880741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
    Tanner MM; Grenman S; Koul A; Johannsson O; Meltzer P; Pejovic T; Borg A; Isola JJ
    Clin Cancer Res; 2000 May; 6(5):1833-9. PubMed ID: 10815905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines.
    Imoto I; Pimkhaokham A; Watanabe T; Saito-Ohara F; Soeda E; Inazawa J
    Biochem Biophys Res Commun; 2000 Sep; 276(1):264-70. PubMed ID: 11006116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
    Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
    Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
    Tanner MM; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan XY; Trent J; Gray JW; Meltzer P; Kallioniemi OP
    Cancer Res; 1996 Aug; 56(15):3441-5. PubMed ID: 8758909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers.
    Buffart TE; van Grieken NC; Tijssen M; Coffa J; Ylstra B; Grabsch HI; van de Velde CJ; Carvalho B; Meijer GA
    Virchows Arch; 2009 Sep; 455(3):213-23. PubMed ID: 19697059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma.
    Rahman MT; Nakayama K; Rahman M; Nakayama N; Ishikawa M; Katagiri A; Iida K; Nakayama S; Otsuki Y; Shih IeM; Miyazaki K
    Cancer; 2012 Jun; 118(11):2846-57. PubMed ID: 22139760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.
    Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
    Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner MM; Zeillinger R; Theillet C
    Br J Cancer; 1996 Dec; 74(12):1984-9. PubMed ID: 8980401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.
    Weiss MM; Snijders AM; Kuipers EJ; Ylstra B; Pinkel D; Meuwissen SG; van Diest PJ; Albertson DG; Meijer GA
    J Pathol; 2003 Jul; 200(3):320-6. PubMed ID: 12845628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The candidate oncogene ZNF217 is frequently amplified in colon cancer.
    Rooney PH; Boonsong A; McFadyen MC; McLeod HL; Cassidy J; Curran S; Murray GI
    J Pathol; 2004 Nov; 204(3):282-8. PubMed ID: 15476264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncogene ZNF217 amplification on chromosome 20 q in ovarian serous cystadenocarcinoma and its clinical implications].
    Li J; Zhong M; Song LL; Su GD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):824-5. PubMed ID: 16793610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.
    Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR
    Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression.
    Peiró G; Diebold J; Löhrs U
    Am J Clin Pathol; 2002 Dec; 118(6):922-9. PubMed ID: 12472286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
    Mahlamäki EH; Bärlund M; Tanner M; Gorunova L; Höglund M; Karhu R; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):353-8. PubMed ID: 12378529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations.
    Huang HN; Huang WC; Lin CH; Chiang YC; Huang HY; Kuo KT
    Hum Pathol; 2014 Nov; 45(11):2318-25. PubMed ID: 25281027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic array and expression analysis of frequent high-level amplifications in adenocarcinomas of the gastro-esophageal junction.
    van Dekken H; Vissers K; Tilanus HW; Kuo WL; Tanke HJ; Rosenberg C; Ijszenga M; Szuhai K
    Cancer Genet Cytogenet; 2006 Apr; 166(2):157-62. PubMed ID: 16631473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
    Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.